|
1
|
Lodi G, Sardella A, Bez C, Demarosi F and
Carrassi A: Interventions for treating oral leukoplakia. Cochrane
Database Syst Rev. 18:CD0018292006.
|
|
2
|
Silverman S Jr, Gorsky M and Lozada F:
Oral leukoplakia and malignant transformation. A follow-up study of
257 patients. Cancer. 53:563–568. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van der Waal I: Potentially malignant
disorders of the oral and oropharyngeal mucosa; terminology,
classification and present concepts of management. Oral Oncol.
45:317–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Papadimitrakopoulou VA, Hong WK, Lee JS,
Martin JW, Lee JJ, Batsakis JG and Lippman SM: Low-dose
isotretinoin versus beta-carotene to prevent oral carcinogenesis:
Long-term follow-up. J Natl Cancer Inst. 89:257–258. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schepman KP, van der Meij EH, Smeele LE
and van der Waal I: Malignant transformation of oral leukoplakia: A
follow-up study of a hospital-based population of 166 patients with
oral leukoplakia from The Netherlands. Oral Oncol. 34:270–275.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kawaguchi H, El-Naggar AK,
Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong
WK, Lippman SM and Mao L: Podoplanin: A novel marker for oral
cancer risk in patients with oral premalignancy. J Clin Oncol.
26:354–360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitra D, Fernandez P, Bian L, Song N, Li
F, Han G and Wang XJ: Smad4 loss in mouse keratinocytes leads to
increased susceptibility to UV carcinogenesis with reduced
ercc1-mediated DNA repair. J Invest Dermatol. 133:2609–2616. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia RH, Song XM, Wang XJ, Li J and Mao L:
The combination of SMAD4 expression and histological grade of
dysplasia is a better predictor for the malignant transformation of
oral leukoplakia. PLoS One. 8:e667942013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guruharsha KG, Kankel MW and
Artavanis-Tsakonas S: The Notch signalling system: Recent insights
into the complexity of a conserved pathway. Nat Rev Genet.
13:654–666. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng Y, Wang Z, Ding X, Dong Y, Zhang W,
Zhang W, Zhong Y, Gu W, Wu Y and Song X: Combined Erlotinib and
PF-03084014 treatment contributes to synthetic lethality in head
and neck squamous cell carcinoma. Cell Prolif. Dec 12–2017.(Epub
ahead of print). View Article : Google Scholar
|
|
13
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Patturajan M, Nomoto S, Sommer M, Fomenkov
A, Hibi K, Zangen R, Poliak N, Califano J, Trink B and Ratovitski
E: DeltaNp63 induces beta-catenin nuclear accumulation and
signaling. Cancer Cell. 1:369–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sriuranpong V, Borges MW, Ravi RK, Arnold
DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell
cycle arrest in small cell lung cancer cells. Cancer Res.
61:3200–3205. 2001.PubMed/NCBI
|
|
16
|
Yugawa T, Handa K, Narisawa-Saito M, Ohno
S, Fujita M and Kiyono T: Regulation of Notch1 gene expression by
p53 in epithelial cells. Mol Cell Biol. 27:3732–3742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Panelos J, Tarantini F, Paglierani M, Di
Serio C, Maio V, Pellerito S, Pimpinelli N, Santucci M and Massi D:
Photoexposition discriminates Notch 1 expression in human cutaneous
squamous cell carcinoma. Mod Pathol. 21:316–325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang TH, Liu HC, Zhu LJ, Chu M, Liang YJ,
Liang LZ and Liao GQ: Activation of Notch signaling in human tongue
carcinoma. J Oral Pathol Med. 40:37–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao J, Duan L, Fan M and Wu X: Gamma
secretase inhibitors exerts antitumor activity via down-regulation
of Notch and Nuclear factor kappa B in human tongue carcinoma
cells. Oral Dis. 13:555–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin JT, Chen MK, Yeh KT, Chang CS, Chang
TH, Lin CY, Wu YC, Su BW, Lee KD and Chang PJ: Association of high
levels of Jagged-1 and Notch-1 expression with poor prognosis in
head and neck cancer. Ann Surg Oncol. 17:2976–2983. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hijioka H, Setoguchi T, Miyawaki A, Gao H,
Ishida T, Komiya S and Nakamura N: Upregulation of Notch pathway
molecules in oral squamous cell carcinoma. Int J Oncol. 36:817–822.
2010.PubMed/NCBI
|
|
22
|
Duan L, Yao J, Wu X and Fan M: Growth
suppression induced by Notch1 activation involves Wnt-beta-catenin
down-regulation in human tongue carcinoma cells. Biol Cell.
98:479–490. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agrawal N, Frederick MJ, Pickering CR,
Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et
al: Exome sequencing of head and neck squamous cell carcinoma
reveals inactivating mutations in Notch1. Science. 333:1154–1157.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song X, Xia R, Li J, Long Z, Ren H, Chen W
and Mao L: Common and complex Notch1 mutations in chinese
oral squamous cell carcinoma. Clin Cancer Res. 20:701–710. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Izumchenko E, Sun K, Jones S, Brait M,
Agrawal N, Koch WM, McCord C, Riley D, Angiuoli SV, Velculescu VE,
et al: Notch1 mutations are drivers of oral tumorigenesis. Cancer
Prev Res. 8:277–286. 2014. View Article : Google Scholar
|
|
27
|
Cao W, Feng Z, Cui Z, Zhang C, Sun Z, Mao
L and Chen W: Up-regulation of enhancer of zeste homolog 2 is
associated positively with cyclin D1 overexpression and poor
clinical outcome in head and neck squamous cell carcinoma. Cancer.
118:2858–2871. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu W, Liang CG, Li YF, Ji YH, Qiu WJ and
Tang XZ: Involvement of Notch1/Hes signaling pathway in ankylosing
spondylitis. Int J Clin Exp Pathol. 8:2737–2745. 2015.PubMed/NCBI
|
|
29
|
Lakhani SR, Van De Vijver MJ, Jacquemier
J, Anderson TJ, Osin PP, Mcguffog L and Easton DF: The pathology of
familial breast cancer: Predictive value of immunohistochemical
markers estrogen receptor, progesterone receptor, HER-2, and p53 in
patients with mutations in BRCA1 and BRCA2. J Clin
Oncol. 20:2310–2328. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hasina R, Martin LE, Kasza K, Jones CL,
Jalil A and Lingen MW: ABT-510 is an effective chemopreventive
agent in the mouse 4-nitroquinoline 1-oxide model of oral
carcinogenesis. Cancer Prev Res. 2:385–393. 2009. View Article : Google Scholar
|
|
31
|
Chang NW, Pei RJ, Tseng HC, Yeh KT, Chan
HC, Lee MR, Lin C, Hsieh WT, Kao MC, Tsai MH and Lin CF:
Co-treating with arecoline and 4-nitroquinoline 1-oxide to
establish a mouse model mimicking oral tumorigenesis. Chem Biol
Int. 183:231–237. 2010. View Article : Google Scholar
|
|
32
|
South AP, Cho RJ and Aster JC: The
double-edged sword of Notch signaling in cancer. Semin Cell Dev
Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lefort K, Ostano P, Mello-Grand M, Calpini
V, Scatolini M, Farsetti A, Dotto GP and Chiorino G: Dual tumor
suppressing and promoting function of Notch1 signaling in human
prostate cancer. Oncotarget. 7:48011–48026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun W, Gaykalova DA, Ochs MF, Mambo E,
Arnaoutakis D, Liu Y, Loyo M, Agrawal N, Howard J, Li R, et al:
Activation of the Notch pathway in head and neck cancer. Cancer
Rese. 74:1091–1104. 2014. View Article : Google Scholar
|
|
35
|
Upadhyay P, Nair S, Kaur E, Aich J, Dani
P, Sethunath V, Gardi N, Chandrani P, Godbole M, Sonawane K, et al:
Notch pathway activation is essential for maintenance of stem-like
cells in early tongue cancer. Oncotarget. 7:50437–504449. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoshida R, Nagata M, Nakayama H,
Niimori-Kita K, Hassan W, Tanaka T, Shinohara M and Ito T: The
pathological significance of Notch1 in oral squamous cell
carcinoma. Lab Invest. 93:1068–1081. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee SH, Do SI, Lee HJ, Kang HJ, Koo BS and
Lim YC: Notch1 signaling contributes to stemness in head and neck
squamous cell carcinoma. Lab Invest. 96:508–516. 2016.(In English).
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaka AS, Nowacki NB, Kumar B, Zhao S, Old
MO, Agrawal A, Ozer E, Carrau RL, Schuller DE, Kumar P and Teknos
TN: Notch1 overexpression correlates to improved survival in cancer
of the oropharynx. Otolaryngol Head Neck Surg. 156:652–659. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miele L: Notch signaling. Clin Cancer Res.
12:1074–1079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sakamoto K, Fujii T, Kawachi H, Miki Y,
Omura K, Morita K, Kayamori K, Katsube K and Yamaguchi A: Reduction
of Notch1 expression pertains to maturation abnormalities of
keratinocytes in squamous neoplasms. Lab Invest. 92:688–702. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zagouras P, Stifani S, Blaumueller CM,
Carcangiu ML and Artavanis-Tsakonas S: Alterations in Notch
signaling in neoplastic lesions of the human cervix. Proc Natl Acad
Sci USA. 92:6414–6418. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ahmad I, Zaqouras P and Artavanis-Tsakonas
S: Involvement of Notch-1 in mammalian retinal neurogenesis:
Association of Notch-1 activity with both immature and terminally
differentiated cells. Mech Dev. 53:73–85. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Izumchenko E, Sun K, Jones S, Brait M,
Agrawal N, Koch W, McCord CL, Riley DR, Angiuoli SV, Velculescu VE,
et al: Notch1 mutations are drivers of oral tumorigenesis. Cancer
Prev Res. 8:277–286. 2015. View Article : Google Scholar
|
|
45
|
Zweidler-Mckay PA, He Y, Xu L, Rodriguez
CG, Karnell FG, Carpenter AC, Aster JC, Allman D and Pear WS: Notch
signaling is a potent inducer of growth arrest and apoptosis in a
wide range of B-cell malignancies. Blood. 106:3898–3906. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nicolas M, Wolfer A, Raj K, Kummer JA,
Mill P, van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F:
Notch1 functions as a tumor suppressor in mouse skin. Nat Genet.
33:416–421. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zheng Y, Wang Z, Ding X, Zhang W, Li G,
Liu L, Wu H, Gu W, Wu Y and Song X: A novel Notch1 missense
mutation (C1133Y) in the Abruptex domain exhibits enhanced
proliferation and invasion in oral squamous cell carcinoma. Cancer
Cell Int. 18:62018. View Article : Google Scholar : PubMed/NCBI
|
